Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fe Curis
- Development stage
- Unknown
- Lead developer
- Curis
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fe Curis is a hematinic pharmaceutical formulation developed and marketed by Biocuris Pharma. It is a combination product typically containing ferrous ascorbate and folic acid (Vitamin B9). Ferrous ascorbate is a synthetic molecule of ascorbic acid and ferrous iron that provides a highly bioavailable source of elemental iron, which is essential for the synthesis of hemoglobin. Folic acid is a critical coenzyme in the synthesis of nucleoproteins and the maintenance of normal erythropoiesis. Fe Curis is primarily indicated for the treatment and prevention of iron deficiency anemia and folic acid deficiency, particularly during pregnancy, lactation, and in cases of nutritional deficiency.
- Brand names
- Fe Curis
02
Targets
DNA
Beyond the preview
Go deeper on Fe Curis.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fe Curis.